Some of its top holdings include Caterpillar, Pentair, AbbVie, AFLAC, General Dynamics, Clorox Co., Walmart, Hormel Foods, ...

In the wake of the presidential election, another change in interest rates and continued news about geopolitical unrest, the appeal of blue-chip stocks is stronger than ever. That's because these ...

Axsome Therapeutics' Q3 2024 earnings report shows a revenue beat with $104.8m. See why I think selling AXSM stock on any ...

Morgan Stanley lowered the firm’s price target on AbbVie (ABBV) to $224 from $231 and keeps an Overweight rating on the shares following ...

Dividend yield and robust drug pipeline are bullish ... Data by YCharts Shares of AbbVie experienced one of their worst ...

AbbVie shares, which hit a 52-week high in late October after the drugmaker posted quarterly earnings that topped Wall Street's expectations and raised its dividend by nearly 6%, were recently down ...

In trading on Monday, shares of AbbVie crossed below their 200 day moving average of $178.81, changing hands as low as $172.70 per share.

AbbVie stock drops after Phase 2 trials of emraclidine fail to meet primary endpoint. The company continues data analysis for ...

Dividend growth stocks offer a unique blend of reliability and growth potential, making them an ideal choice for long-term ...

However, arguably the next best thing is for a company to belong to the elite group known as Dividend Kings. To qualify, a ...

Strategists at Wells Fargo Investment Institute see the fed funds rate dropping a total of one percentage point this year and ...